The Global Endometrial Cancer Market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million by 2021.
Endometrial cancer is a common form of cancer of the female reproductive system that initiates in the lining of the uterus. The National Cancer Institute recorded that the number of new cases of endometrial cancer was 25.4 per 100,000 women per year based on the 2009-2013 cases studied. Endometrial cancer is most frequently diagnosed among women aged 55-64 years. As per the American Cancer Society endometrial cancer is the most common cancer of the female reproductive organs in the US. About 60,050 new cases of cancer of the body of the uterus (uterine body or corpus) are estimated to be diagnosed during 2016 and about 10,470 women are expected to die from cancers of the uterine body, during the same year.
Global Endometrial Cancer – Market Dynamics
The report details several factors driving and restraining the market, some of which are discussed below.
Rise in awareness about Uterine diseases and their available therapies
Increasing health care expenditure
Innovation in drug development, and subsequent technological advancements
Low success rates in clinical trials for cancer drugs
High cost associated with the treatment
Adverse side-effects of treatment and high toxicity of drugs
Get a PDF Sample of Global Endometrial Cancer Market Research Report @: http://www.orbisresearch.com/contacts/request-sample/220503
The global endometrial cancer market has been segmented by type of cancer into endometrial carcinoma and uterine sarcoma. The market can be classified by type of therapy into surgery, immunotherapy, radiation therapy, chemotherapy, and follow-up treatment. Chemotherapy agents include drugs such as Paclitaxel (Taxol ®), Carboplatin, Doxorubicin (Adriamycin ®) or liposomal doxorubicin (Doxil ®), and Cisplatin. The global endometrial cancer market, by diagnosis type, can be divided into biopsy, pelvic ultrasound, hysteroscopy, dilation and curettage, and CT Scan. The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.
Some of the key players in the market are:
Becton, Dickinson & Co.
What the Report Offers
Market definition, along with identification of key drivers and restraints for the market.
Market analysis with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
Place Purchase Order of this Report @: http://www.orbisresearch.com/contact/purchase/220503